Author:
Cao Gang,Zhu Ruyi,Jiang Ting,Tang Dongxin,Kwan Hiu Yee,Su Tao
Funder
Chinese Medicine Research Program of Zhejiang Province, China
Opening Project of Zhejiang Provincial
Zhejiang Chinese Medical University
Public Welfare Application Project of Zhejiang Province
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference63 articles.
1. Adipose tissue content of transforming growth factor (TGF-B1) is associated with hepatic fibrosis in morbidly obese subjects with non-alcoholic fatty liver disease;Abrams;Hepatology,2004
2. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis;Arthur;Am. J. Physiol.-Gastr. L.,2000
3. Clinical advancements in the targeted therapies against liver fibrosis;Bansal;Mediat. Inflamm.,2016
4. 'Ashvagandharishta' prepared using yeast consortium from Woodfordia fruticosa flowers exhibit hepatoprotective effect on CCl4 induced liver damage in Wistar rats;Bhondave;J. Ethnopharmacol.,2014
5. Transforming growth factor beta and the liver;Bissell;Hepatology,2001
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献